-transparent.png){kind=logo}
Fifty-one renal and marrow graft recipients have been treated with whole, absorbed rabbit anti-human-lymphocyte serum. Such sera are potent nontoxic immunosuppressive agents. Preexisting sensitivity can be erased, and early rejection episodes are essentially eliminated. Prolonged treatment is necessary and safe, and it ensures a sustained depression in circulating T cells. Adaptation between kidney graft and host then occurs, so that the combination of prednisone and Imuran alone can sustain graft viability.
Related Publications
R H Levey, and
R Parkman
February 1968,
Annals of internal medicine,
R H Levey, and
R Parkman
January 1971,
Folia allergologica,
R H Levey, and
R Parkman
June 1970,
Transplantation,
R H Levey, and
R Parkman
January 1972,
The Laryngoscope,
R H Levey, and
R Parkman
December 1972,
Transplantation proceedings,
R H Levey, and
R Parkman
March 1971,
Transplantation proceedings,
R H Levey, and
R Parkman
January 1997,
Pharmacotherapy,
R H Levey, and
R Parkman
January 1971,
Polish medical journal,
R H Levey, and
R Parkman
January 1970,
Lancet (London, England),
R H Levey, and
R Parkman
January 1991,
Transplantation,
